| abstract |
The invention provides gene markers, kits and detection methods for detecting benign and malignant liver tumors. Detection of FAT atypical cadherin 1, estrogen-related receptor gamma, sex-determining gene y chromosome region cassette family member 9, cilia-like complex subunit 1, chromosome 1 open reading frame 125 antibody by high-throughput sequencing, Content of 5-hydroxymethylcytosine in one or more marker genes of filament protein, transferrin, TNF receptor superfamily members, pancreas and duodenum, and α-acid glycoprotein 2 To determine the benign and malignant liver tumors |